PMC:7299399 / 30127-30290
Annnotations
LitCovid-PD-FMA-UBERON
| Id | Subject | Object | Predicate | Lexical cue | fma_id |
|---|---|---|---|---|---|
| T128 | 69-71 | Body_part | denotes | IL | http://purl.org/sig/ont/fma/fma86578 |
| T129 | 96-98 | Body_part | denotes | IL | http://purl.org/sig/ont/fma/fma86578 |
| T130 | 110-118 | Body_part | denotes | antibody | http://purl.org/sig/ont/fma/fma62871 |
| T131 | 138-140 | Body_part | denotes | IL | http://purl.org/sig/ont/fma/fma86578 |
LitCovid-PD-CLO
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T280 | 28-35 | http://purl.obolibrary.org/obo/UBERON_0000473 | denotes | testing |
LitCovid-PD-CHEBI
| Id | Subject | Object | Predicate | Lexical cue | chebi_id |
|---|---|---|---|---|---|
| T221 | 36-41 | Chemical | denotes | drugs | http://purl.obolibrary.org/obo/CHEBI_23888 |
| T222 | 69-71 | Chemical | denotes | IL | http://purl.obolibrary.org/obo/CHEBI_63895|http://purl.obolibrary.org/obo/CHEBI_74072 |
| T224 | 96-98 | Chemical | denotes | IL | http://purl.obolibrary.org/obo/CHEBI_63895|http://purl.obolibrary.org/obo/CHEBI_74072 |
| T226 | 138-140 | Chemical | denotes | IL | http://purl.obolibrary.org/obo/CHEBI_63895|http://purl.obolibrary.org/obo/CHEBI_74072 |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T117 | 0-163 | Sentence | denotes | Ongoing clinical trials are testing drugs that block the receptor of IL-6 (Tocilizumab, an anti-IL-6 receptor antibody, and Sarilumab) or IL-6 itself (Siltuximab). |
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 465 | 69-73 | Gene | denotes | IL-6 | Gene:3569 |
| 466 | 96-100 | Gene | denotes | IL-6 | Gene:3569 |
| 467 | 138-142 | Gene | denotes | IL-6 | Gene:3569 |
| 471 | 75-86 | Chemical | denotes | Tocilizumab | MESH:C502936 |
| 472 | 124-133 | Chemical | denotes | Sarilumab | MESH:C000592401 |
| 473 | 151-161 | Chemical | denotes | Siltuximab | MESH:C504234 |